Venue: London – UK
Dates: 12 – 13 October 2017
After two successful editions, MarketsandMarkets has announced the 3rd Annual Epigenetics Discovery Congress, which will be taking place on the 12 – 13 October 2017 in London, UK.
With a tremendous progress in technology to generate and analyze reference epigenomes, the epigenetics field is fetching a lot of importance and attention across all medical science’s areas. Additionally, novel epigenetic molecules across many target classes for drug discovery, have been the prime focus of the pharmaceutical industry.
To meet and support this pace of the epigenetics research and development field, the 3rd Annual Epigenetics Discovery Congress will present novel research and address challenges right from the molecular sciences & disease diagnosis to drug discovery streams. The congress will also be a great platform to learn about novel technologies like next generation sequencing and single cell analysis.
For further information contact Mr Amit Shelke at email@example.com
As a reader of Biotechin.Asia you are entitled to 20% discount on registration fees. Use discount code (MM-BioTI)